Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2004-09-10
2009-12-01
Zalukaeva, Tatyana (Department: 3761)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C604S006010, C604S005010, C604S006030, C604S005040, C604S005020, C422S044000, C422S048000, C210S634000, C210S636000, C210S638000, C210S645000, C210S646000, C210S650000, C210S654000, C210S660000, C210S669000, C210S781000, C210S782000, C210S800000, C210S806000, C210S260000
Reexamination Certificate
active
07625351
ABSTRACT:
Provided herein is an innovative hemoperfusion system and method including a thermal-fused broad-spectrum biocidal iodinated interactive polymer for the treatment of biological contaminants in body fluids. In one exemplary embodiment, the system and method utilizes a Triosyn® thermal fused broad-spectrum iodinated interactive polymer, included in a hemoperfusion column, for devitalizing high levels of cell-free microorganisms in whole blood and biological fluids in relation with the characterization of blood cells viability and function post-treatment.
REFERENCES:
patent: 4140652 (1979-02-01), Korshak et al.
patent: 4248736 (1981-02-01), Fuchigami et al.
patent: 4401430 (1983-08-01), Dorson et al.
patent: 5240601 (1993-08-01), Mazid
patent: 5360605 (1994-11-01), Shanbrom
patent: 5370869 (1994-12-01), Shanbrom
patent: 5545401 (1996-08-01), Shanbrom
patent: 5609864 (1997-03-01), Shanbrom
patent: 5639452 (1997-06-01), Messier
patent: 5693452 (1997-12-01), Aoai et al.
patent: 6045787 (2000-04-01), Shanbrom
patent: 6045820 (2000-04-01), Messier
patent: 6096216 (2000-08-01), Shanbrom et al.
patent: 6106773 (2000-08-01), Miekka et al.
patent: 6407212 (2002-06-01), Morgenthaler et al.
patent: 6544727 (2003-04-01), Hei
patent: 6736972 (2004-05-01), Matson
patent: 7229427 (2007-06-01), Mallett et al.
patent: 2002/0045157 (2002-04-01), Hirai et al.
patent: 2002/0058032 (2002-05-01), Hirai et al.
patent: 2002/0197252 (2002-12-01), Brady et al.
patent: 2005/0042131 (2005-02-01), Gartner
patent: PCT/US2004/029398 (2005-07-01), None
Adams GA, Swenson SD, Rock G. 1986. Survival and recovery of human platelets stored for five days in a non-plasma medium. Blood, vol. 67:3 pp. 672-675.
American Association of Blood Banks, America's Blood Centers and the American Red Cross. (Aug. 2000) Circular of Information for the use of human blood and blood components pp. 1-32.
America's Blood Centers. “Bacterial Contamination of Blood Components” Jul. 2000. Online at: http://66.155.15.152/medical/bulletin—v3—n2.htm.
Amy D. Shapiro, M.D., Indiana Hemophilia and Thrombosis Center, Indianapolis, U.S.A. (1999) Platelet Function Disorders. Treatment of Hemophilia Monograph Series, No. 19. World Federation of Hemophilia: pp. 1-11.
Arthur P. Bode. (1990) Platelet Activation May Explain the Storage Lesion in Platelet Concentrates., Blood Cells (1990) vol. 16: pp. 109-126.
AuBuchon JP.; Pickard C.; Herschel L.; O'Connor JL.. Documentation of efficient leukocyte removal with a new filter. Transfusion, vol. 38:64S.
AuBuchon JP; Dodd RY. 1992. Inactivation of Microbial Contaminants of Blood Components. Clin Lab Med, vol. Dec. 12:4, pp. 787-803.
AuBuchon JP.; Elfath MD.; Popovskyk MA.; Stromberg RR.; Pickard C.; Herschel L.; Whitley P.; McNeil D.; Arnold N.; O'Connor JL.. 1997. Evaluation of a new prestorage leukoreduction filter for red blood cells. Vox Sang, vol. 72, pp. 101-106.
Buchholz DH.; AuBuchon JP.; Snyder EL.; Kandler R.; Piscitelli V.; Pickard C.; Napychank P.; Edberg S.. 1994. Effects of leukocyte reduction of the resistance of blood components to bacterial multiplication. Transfusion, vol. 34, pp. 852-857.
Wylie BR. 1993. Transfusion transmitted infection: viral and exotic diseases. Anaesth Intensive Care, vol. Feb. 21:1, pp. 24-30.
Barret BB.; Anderson.; JW.; Anderson KC.. 1993. Strategies for the avoidance of bacterial contamination of blood components. Transfusion, vol. Mar. 33:3, pp. 228-233.
Beutler, E., 1984. Determination of 2,3-Diphosphoglycerate in Erythrocytes. Red Cell Metabolism . A Manual of Biochemical Methods. 3rd ed. Orlando, Grune & Stratton, pp. 127-12.
Beaujean F, SegierJM, Le Forestier C, Duedari N. 1992. Leukocyte depletion of red cell concentrates by filtration: influence of blood product temperature. Vox Sang, vol. 62:4, pp. 242-243.
Bertolini F, Porretti L, Lauri E, Rebulla P, Sirchia G. 1993. Role of lactate in platelet storage lesion. Vox Sanguinis vol. 65 pp. 194-198.
Bertolini, F. and Murphy, S. (1994) A multicenter evaluation of reproducibility of swirling in platelet concentrates., Transfusion vol. 34, pp. 796-801.
Blajchman MA.. 1995. Bacterial contamination of blood products and the value pretransfusion testing. Immunol Invest, vol. Jan.-Feb. 24:1-2, pp. 163-170.
Blajchman MA.; Ali AM,; Richardson HL..1994. Bacterial contamination of blood components. Vox Sang, vol. 67 suppl 3, pp. 25-33.
Bove Jr..1990. Transfusion- transmitted diseases other then AIDS and hepatitis. Yale J Biol Med, vol. Sep.-Oct. 63:5, pp. 347-351.
Weber, David J., Barbee, Susan L., Sobsey, Mark D. and Rutala, William A. 1999. The Effect of Blood on the Antiviral Activity of Sodium Hypochlorite, a Phenolic, and a Quaternary Ammonium Compound. Infection Control and Hospital Epidemiology, vol. 20, pp. 821-827.
Wallas, C.H.; 1979. Sodium and Potassium Changes in Blood Bank Stored Human Erythrocytes. Transfusion, 19(2), pp. 210-215.
Busch MP; Lee T.. 1995. Role of Donor Leukocytes and Leukodepletion in transfusion-Associated Viral Infections. Clinical Benefits of Leukodepleted Blood Products. edited by Joseph Sweeney, M.D. and Andrew Heaton, M.D.,R.G. Landes Company, chapter 8, pp. 99-112.
Cabantchik, Z.I., Silfen J., Firestone R.A., Krugliak M., Nissani E. and Ginsburg H., 1989. Effects of Lysosomotropic Detergents on the Human Malarial Parasite Plasmodium Falciparum in In Vitro Culture. Biochemical Pharmacology, vol. 38, No. 8, pp. 1271-1277.
Wagner SJ.; Friedman LI.; Dodd RY.. 1994. Transfusion-associated bacterial sepsis. Clin Microbiol Rev, vol. Jul. 7:3, pp. 290-302.
Van der Meer PF, Pietersz RN, Nelis JT, Hinloopen B, Dekker WJ, Reesink HW, 1999. Six filters for the removal of white cells from red cell concentrates, evaluated at 4 degrees.
Chu RW. 1999. Leukocytes in Blood Transfusion: Adverse effects and their prevention. HKMJ, vol. 5, No. 3, pp. 280-284.
Coleman, Roger; Holdsworth, George. 1975. Effects of Detergents on Erythrocyte Membranes: Different Patterns of Solubilization of the Membrane Proteins by Dihydroxy and Trihydroxy Bile Salts. Biochemical Society Transactions, vol. 3, pp. 747-748.
Corash, Laurence, 1999. Inactivation of Viruses, Bacteria, Protozoa, and Leukocytes in Platelets Concentrates: Current Research Perspectives, Transfusion Medicine Reviews, vol. 13:1, pp. 18-30.
Dodd RY. 1998. Transmission of Parasites by Blood Transfusion. Vox Sang, vol. 74, suppl. 2, pp. 161-163.
Dodd RY. 1992. The risk of transfusion-transmitted infection. New England Journal of Medicine, vol. Aug. 6 327:6, pp. 419-421.
Dodd, RY., 1990. Will Blood Products Be Free of Infectious Agents? : Transfusion Medicine in the 1990's. In Nance SJ ed. Arlington, VA, American Association of Blood Banks, pp. 223-251.
Fratantoni, J.C., Poindexter, B.J., and Bonner, R.F. (1984) Quantitative assessment of platelet morphology by light scattering: a potential method for the evaluation of platelets for transfusion., J. Lab. Clin. Med vol. 103, pp. 620-631.
G.A. Becker, M. Tuccelli, T. Kunicki, M. K. Chalos and R. H. Aster. (1973) Studies of Platelet Concentrates Stored at 22 C and 4 C., Transfusion vol. 13, pp. 61-68.
Valeri CR, Feingold H, Marchionni LD, 1974. The relation between response to hypotonic stress and 51-Cr recovery in vivo of preserved platelets. Transfusion, vol. 14, pp. 331-337.
Girotti S., Ferri E., Cascione ML., Orlandini A., Farina L., Nucci S., Di Graci F., Budini R., 1991. Methodological Problems of Direct Bioluminescent ADP assay in Platelets and Erythrocytes. Anal. Biochem., Feb. 1, vol. 192, No. 2, pp. 350-357.
Gómez-Abonés, X.; Pinacho, A.; Ortiz, P.; Maciá, J.; Gallart, M.; Araguás, C.; Sánchez, J.M.; Teixidó. A Simple Flow-Cytometric Method For Absolute Counting of Residual White Blood Cells in Leukocyte-Reduced Packed Red Cells. Vox Sanguinis. vol. 76, pp. 64-65.
Greenwalt, TJ and Allen, CM, 1990. A Method for Counting Leukocytes in Filtered Components. Transfusion, vol. 30, No. 4, pp. 377-379.
Harmening, Denisi M., 1991. Clot Retraction, Platelet Retention/ Adhesion, Platelet Aggregation, Platelet Factor 3 Availability. Clinical He
Chapman Ginger T
Messier Pierre J.
Triosyn Holding Inc.
Triosyn Holding Inc.
Zalukaeva Tatyana
LandOfFree
System, method and apparatus for purifying biological fluids... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System, method and apparatus for purifying biological fluids..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System, method and apparatus for purifying biological fluids... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4115633